相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
6266-66-6
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg/100 mg/200 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥665.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥206.0 |
| 规格: | 5 mg | 产品价格: | ¥437.0 |
| 规格: | 10 mg | 产品价格: | ¥644.0 |
| 规格: | 25 mg | 产品价格: | ¥922.0 |
| 规格: | 50 mg | 产品价格: | ¥1475.0 |
| 规格: | 100 mg | 产品价格: | ¥2065.0 |
| 规格: | 200 mg | 产品价格: | ¥3163.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
PEO-IAA
CAS No. : 6266-66-6
MCE 国际站:PEO-IAA
产品活性:PEO-IAA 是一种吲哚-3-乙酸 (IAA) 拮抗剂,是一种生长素拮抗剂,可与转运抑制剂响应蛋白 1/生长素信号 F-box 蛋白 (TIR1/AFBs) 结合。
研究领域:Others
作用靶点:Others
In Vitro: PEO-IAA is also an α-alkyl-IAA, and shows more potent anti-auxin activity in auxin-responsive gene expression and in the cell division and elongation pathway that is mediated via SCFTIR1/AFBs. PEO-IAA suppresses not only the expression of an auxin-responsive ZmSAUR2 gene, but also gravitropic curvature. PEO-IAA blocks the auxin response in Arabidopsis, rice, moss and maize.
相关产品:Bioactive Compound Library Plus | Digitonin | 5-Ph-IAA | FLAG peptide | Tocofersolan | Monocrotaline | Lactate sodium | TCEP hydrochloride | 3X FLAG peptide | DPPH | Pertussis Toxin | Pronase E (Activity ≥ 7000 U/g) | O-Propargyl-Puromycin | NMDI14 | Phytohemagglutinin | MYLS22 | Hyaluronidase | Biotinyl tyramide | Kifunensine | Human IgG1 kappa, Isotype Control | 4-Azido-L-phenylalanine | 6-Aminonicotinamide | Ammonium tetrathiomolybdate(VI) | OVA Peptide(257-264) TFA | Alkyne-phenol | Lauryl maltose neopentyl glycol | SHIN1 | CHAPS | Cytosporone B
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
技术资料暂无技术资料 索取技术资料

















